Clinical Trial

Transfusion Exchanges and Cognition in Sickle Cell Disease

Study acronym: DREPA-COG
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
DREPA-COG is an observational study evaluating the effect of exchange transfusions on cognitive function in adults with severe sickle cell disease (SS or Sβ0). Information processing speed is assessed at three time points during the transfusion cycle using the Symbol Digit Modalities Test (SDMT) and additional validated neuropsychological measures. This minimal-risk, fully remote study aims to identify processing speed as a reproducible marker for clinical monitoring and future therapeutic trials.
Trial Details
NCT Number NCT07168447
Lead Sponsor Centre Hospitalier St Anne
Conditions Drepanocytosis, Chronic Neurological Deficiency
Enrollment 85 participants
Start Date 2025-12-03
Primary Completion 2027-11-02 (estimated)
Study Completion 2027-11-02 (estimated)
Updated on ClinicalTrials.gov 2025-09-11